BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37686122)

  • 41. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
    Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J
    Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular profile of lung cancer in never smokers.
    Subramanian J; Govindan R
    EJC Suppl; 2013 Sep; 11(2):248-53. PubMed ID: 26217134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Gene Expression and Clinical Characteristics of Molecular Targeted Therapy 
in Non-small Cell Lung Cancer Patients in Shandong].
    Qiao X; Ai D; Liang H; Mu D; Guo Q
    Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):14-20. PubMed ID: 28103968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigation on the prognostic impact of concurrent genomic alterations in crizotinib-treated EML4-ALK-rearranged advanced non-small cell lung cancer patients.
    Zheng J; Zhu Y; Sun K; Shen Q; Wang Y; Cao H; Lizaso A; Yu B; Lin J; Chen S; Zhou J; Zhou J
    Lung Cancer; 2020 Aug; 146():209-216. PubMed ID: 32563740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The biology and treatment of EML4-ALK non-small cell lung cancer.
    Sasaki T; Rodig SJ; Chirieac LR; Jänne PA
    Eur J Cancer; 2010 Jul; 46(10):1773-80. PubMed ID: 20418096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC.
    He Y; Chen L; Zhao L; Dang S; Liu G; Sasada S; Ma PC; van Zandwijk N; Rosell R; Popper HH; Wang H; Jiang M; Guo H; Liu X; Chen S; Zhang X; Xu M; Zhu B; Liu M; Zhou C
    Theranostics; 2021; 11(14):7092-7109. PubMed ID: 34093873
    [No Abstract]   [Full Text] [Related]  

  • 47. New insights into anaplastic lymphoma kinase-positive nonsmall cell lung cancer.
    Dubey AP; Pathi N; Viswanath S; Rathore A; Pathak A; Sud R
    Indian J Cancer; 2017; 54(1):203-208. PubMed ID: 29199691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas.
    Paik PK; Johnson ML; D'Angelo SP; Sima CS; Ang D; Dogan S; Miller VA; Ladanyi M; Kris MG; Riely GJ
    Cancer; 2012 Dec; 118(23):5840-7. PubMed ID: 22605530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics of the immune microenvironment and their clinical significance in non-small cell lung cancer patients with ALK-rearranged mutation.
    Zhang B; Zeng J; Zhang H; Zhu S; Wang H; He J; Yang L; Zhou N; Zu L; Xu X; Song Z; Xu S
    Front Immunol; 2022; 13():974581. PubMed ID: 36159860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effective enrichment strategy for EML4-ALK fusion gene screening in patients with non-small cell lung cancer.
    Kobayashi M; Sakakibara T; Inoue A; Fukuhara T; Sasano H; Ichinose M; Nukiwa T
    Respir Investig; 2014 Jan; 52(1):49-56. PubMed ID: 24388371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ALK Mutation Status in EGFR-negative Non-small-cell Lung Cancer Patients in Bulgaria.
    Djambazov SN; Vekov TY; Mekov EV; Slavchev GS; Petkov RE; Kostadinov DT; Konteva LT
    Folia Med (Plovdiv); 2018 Sep; 60(3):397-401. PubMed ID: 30355843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anaplastic lymphoma kinase translocation is correlated with anaplastic lymphoma kinase expression and mutually exclusive with epidermal growth factor receptor mutation in Taiwanese non-small cell lung cancer.
    Hsu SC; Hung TH; Wang CW; Ng KF; Chen TC
    Pathol Int; 2015 May; 65(5):231-9. PubMed ID: 25708242
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations.
    Lim JU; Yeo CD; Rhee CK; Kim YH; Park CK; Kim JS; Kim JW; Lee SH; Kim SJ; Yoon HK; Kim TJ; Lee KY
    PLoS One; 2015; 10(11):e0142306. PubMed ID: 26555338
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    Ren W; Zhang BO; Ma J; Li W; Lan J; Men H; Zhang Q
    Oncol Lett; 2015 Dec; 10(6):3385-3392. PubMed ID: 26788139
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum carcinoembryonic antigen levels before initial treatment are associated with EGFR mutations and EML4- ALK fusion gene in lung adenocarcinoma patients.
    Wang WT; Li Y; Ma J; Chen XB; Qin JJ
    Asian Pac J Cancer Prev; 2014; 15(9):3927-32. PubMed ID: 24935562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability.
    Thu KL; Vucic EA; Chari R; Zhang W; Lockwood WW; English JC; Fu R; Wang P; Feng Z; MacAulay CE; Gazdar AF; Lam S; Lam WL
    PLoS One; 2012; 7(3):e33003. PubMed ID: 22412972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Research progress in non-small cell lung cancer with concomitant EML4-ALK fusion gene and EGFR gene mutation].
    Zeng Z; Wu Y
    Zhongguo Fei Ai Za Zhi; 2011 Nov; 14(11):880-4. PubMed ID: 22104224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advanced Non-Small Cell Lung Cancer: Sequencing Agents in the EGFR-Mutated/ALK-Rearranged Populations.
    Singhi EK; Horn L; Sequist LV; Heymach J; Langer CJ
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e187-e197. PubMed ID: 31099642
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genomic and evolutionary classification of lung cancer in never smokers.
    Zhang T; Joubert P; Ansari-Pour N; Zhao W; Hoang PH; Lokanga R; Moye AL; Rosenbaum J; Gonzalez-Perez A; Martínez-Jiménez F; Castro A; Muscarella LA; Hofman P; Consonni D; Pesatori AC; Kebede M; Li M; Gould Rothberg BE; Peneva I; Schabath MB; Poeta ML; Costantini M; Hirsch D; Heselmeyer-Haddad K; Hutchinson A; Olanich M; Lawrence SM; Lenz P; Duggan M; Bhawsar PMS; Sang J; Kim J; Mendoza L; Saini N; Klimczak LJ; Islam SMA; Otlu B; Khandekar A; Cole N; Stewart DR; Choi J; Brown KM; Caporaso NE; Wilson SH; Pommier Y; Lan Q; Rothman N; Almeida JS; Carter H; Ried T; Kim CF; Lopez-Bigas N; Garcia-Closas M; Shi J; Bossé Y; Zhu B; Gordenin DA; Alexandrov LB; Chanock SJ; Wedge DC; Landi MT
    Nat Genet; 2021 Sep; 53(9):1348-1359. PubMed ID: 34493867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proportion and clinical features of never-smokers with non-small cell lung cancer.
    Cho J; Choi SM; Lee J; Lee CH; Lee SM; Kim DW; Yim JJ; Kim YT; Yoo CG; Kim YW; Han SK; Park YS
    Chin J Cancer; 2017 Feb; 36(1):20. PubMed ID: 28179026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.